Supplementary Figure 2 from Antagonism of SET Using OP449 Enhances the Efficacy of Tyrosine Kinase Inhibitors and Overcomes Drug Resistance in Myeloid Leukemia
Year: 2023
Type: supplementary-materials
Abstract: PDF file - 212KB, SET is overexpressed in primary AML cells and OP449 inhibits growth of primary AML patient cells.
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361818748